Global Similar Biological Medicinal Products Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Similar Biological Medicinal Products market size was valued at US$ 35850 million in 2024 and is forecast to a readjusted size of USD 110050 million by 2031 with a CAGR of 17.6% during review period.
Similar biopharmaceutical products refer to a biological product that is highly similar in quality, safety and efficacy to the original drug biological preparation that has been approved for marketing. This type of drug is not a universal generic drug because the complexity of the original biological drugs (such as proteins, antibodies, etc.) they replicate and the specificity of the production process make identical replication almost impossible.
This report is a detailed and comprehensive analysis for global Similar Biological Medicinal Products market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Similar Biological Medicinal Products market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Similar Biological Medicinal Products market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Similar Biological Medicinal Products market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Similar Biological Medicinal Products market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Similar Biological Medicinal Products
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Similar Biological Medicinal Products market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biotech, CITIC Guojian, Baitai Biology, Saijin Biotechnology, Fuhong Hanlin, Amgen, Eli Lilly, Sandoz, Changchun High-tech, Innovent Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Similar Biological Medicinal Products market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Monoclonal Antibodies
Recombinant Hormone
Immunomodulator
Anti-inflammatory Drugs
Others
Market segment by Application
Blood Disorders
Growth Hormone Deficiency
Chronic and Autoimmune Diseases
Oncology
Others
Major players covered
Biotech
CITIC Guojian
Baitai Biology
Saijin Biotechnology
Fuhong Hanlin
Amgen
Eli Lilly
Sandoz
Changchun High-tech
Innovent Biologics
Pfizer Inc
Novartis AG
Samsung Bioepies Co., Ltd
Coherus Biosciences, Inc.
Celltrion Healthcare
Viatris
Stada Arzneimittel AG
Teva Pharmaceutical Industries Ltd
Intas Pharmaceutical Ltd
LG Life Sciences (LG Chem)
Biocon Limited
Dr. Reddy's Laboratories
BIOCAD
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Similar Biological Medicinal Products product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Similar Biological Medicinal Products, with price, sales quantity, revenue, and global market share of Similar Biological Medicinal Products from 2020 to 2025.
Chapter 3, the Similar Biological Medicinal Products competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Similar Biological Medicinal Products breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Similar Biological Medicinal Products market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Similar Biological Medicinal Products.
Chapter 14 and 15, to describe Similar Biological Medicinal Products sales channel, distributors, customers, research findings and conclusion.
Similar biopharmaceutical products refer to a biological product that is highly similar in quality, safety and efficacy to the original drug biological preparation that has been approved for marketing. This type of drug is not a universal generic drug because the complexity of the original biological drugs (such as proteins, antibodies, etc.) they replicate and the specificity of the production process make identical replication almost impossible.
This report is a detailed and comprehensive analysis for global Similar Biological Medicinal Products market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Similar Biological Medicinal Products market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Similar Biological Medicinal Products market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Similar Biological Medicinal Products market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Similar Biological Medicinal Products market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Similar Biological Medicinal Products
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Similar Biological Medicinal Products market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biotech, CITIC Guojian, Baitai Biology, Saijin Biotechnology, Fuhong Hanlin, Amgen, Eli Lilly, Sandoz, Changchun High-tech, Innovent Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Similar Biological Medicinal Products market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Monoclonal Antibodies
Recombinant Hormone
Immunomodulator
Anti-inflammatory Drugs
Others
Market segment by Application
Blood Disorders
Growth Hormone Deficiency
Chronic and Autoimmune Diseases
Oncology
Others
Major players covered
Biotech
CITIC Guojian
Baitai Biology
Saijin Biotechnology
Fuhong Hanlin
Amgen
Eli Lilly
Sandoz
Changchun High-tech
Innovent Biologics
Pfizer Inc
Novartis AG
Samsung Bioepies Co., Ltd
Coherus Biosciences, Inc.
Celltrion Healthcare
Viatris
Stada Arzneimittel AG
Teva Pharmaceutical Industries Ltd
Intas Pharmaceutical Ltd
LG Life Sciences (LG Chem)
Biocon Limited
Dr. Reddy's Laboratories
BIOCAD
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Similar Biological Medicinal Products product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Similar Biological Medicinal Products, with price, sales quantity, revenue, and global market share of Similar Biological Medicinal Products from 2020 to 2025.
Chapter 3, the Similar Biological Medicinal Products competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Similar Biological Medicinal Products breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Similar Biological Medicinal Products market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Similar Biological Medicinal Products.
Chapter 14 and 15, to describe Similar Biological Medicinal Products sales channel, distributors, customers, research findings and conclusion.
Table of Contents
164 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Similar Biological Medicinal Products by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
